small molecule

REZENOPY

NALOXONE HYDROCHLORIDE

Loss of exclusivityFebruary 2041latest FDA-listed patent expiry

CompanySCIENTURE LLC

Drug detail

Brand name	REZENOPY
Active ingredient	NALOXONE HYDROCHLORIDE
Strength	10MG/SPRAY
Dosage form	SPRAY
Route	NASAL
Modality	Small molecule
FDA approval	April 2024
Marketing status	RX

Listed patents

Patent	Expires	Type
12514854	February 2041	use U-4397
12622903	February 2041	product

Regulatory exclusivity

Code	Expires
NP	April 2027

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from SCIENTURE LLC